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Introduction: Pulmonary rehabilitation has been demonstrated to improve exercise capacity, dyspnoea, quality of
life and to reduce the adverse effects of acute exacerbations. Current guidelines recommend exercise training in
patients with mild to very severe disease. However, there is insufficient data comparing the efficacy of different
training approaches and intensities.
Methods: Between January 2009 and December 2012, 105 COPD patients were screened to participate in the
study. 61 patients were randomly assigned into an individualized training group or into a non-individualized
training group. Both groups exercised once a week for 60 minutes over a time period of three months. At the
beginning and after three months, the following measurements were performed: 6-minute walking test (6-MWT),
health-related quality of life (St. Georges Respiratory Questionnaire; SGRQ and COPD-Assessment-Test; CAT), M.
rectus femoris cross-sectional area, and inflammatory markers in peripheral blood.
Results: Only in the individualized training group we observed a significant change of the 6-MWT (increase of
32.47 m; p = 0.012) and the cross-sectional area of the M. rectus fermoris (increase of 0.57 cm2; p = 0.049), while no
significant changes occurred in the non-individualized training group. Peroxisome-proliferator-activated receptor-γ
coactivator 1α increased in the individualized training only after the three months training period (increase of 0.43
relative copies; p = 0.017), all other myokines and inflammatory markers were not influenced by either of the
programs. The total drop-out-rate was 44.3%.
Conclusion: A low frequency outpatient training program may induce modest improvements in exercise capacity
and muscle mass only if it is performed on an individualized basis.Introduction
Chronic obstructive pulmonary disease (COPD) is charac-
terized by a usually progressive airflow limitation [1]. Extra-
pulmonary comorbid conditions, like cachexia and muscle
atrophy, are frequently observed [2]. Pulmonary rehabilita-
tion has been demonstrated to improve exercise capacity,
muscle metabolism, and quality of life [3,4].* Correspondence: koczulla@med.uni-marburg.de
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unless otherwise stated.Detailed instructions on pulmonary rehabilitation in
COPD have been published [5-7]. However, only a lim-
ited number of studies compared the impact of various
forms and intensities of outpatient training programs in
a randomized fashion [8,9].
The role of exercise effects on the peripheral muscle and
its myokines has been acknowledged [10]. The underlying
mechanism of exercise training includes the expression of
the transcription factor peroxisome-proliferator-activated
receptor-γ coactivator 1α (PGC1-α) [11-16]. PGC1-α stim-
ulates the expression of FNDC5, a membrane protein that
is cleaved and secreted as a newly identified hormone calledl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Trial profile. 105 stable COPD patients were screened,
and 61 patients were randomized in a 1:1 ratio. 34 patients (IT = 20;
NT = 14) finalized the program. Abbreviations are explained in
the text.
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attenuate inflammation [18].
The most effective frequency of pulmonary rehabilitation
is not known [6]. Most pulmonary rehabilitation studies
demonstrating benefits are based on at least two sessions
per week [19]. However, a recent review article pointed
out that only a small proportion of enrolled patients dem-
onstrated continued commitment raising the question
whether a once-weekly training program would be associ-
ated with better compliance [20].
We conducted a randomized controlled trial to compare
the effects of two different training approaches on exercise
capacity, QoL, muscle mass, myokines and serum inflam-
matory markers. Furthermore, screening failure rates and
drop-out rates were assessed.
Methods
Study outline
Between January 2009 and December 2012 we invited 105
patients with mild to very severe COPD to participate in
our study. We included stable COPD patients based on the
diagnostic criteria published by GOLD [1]. Only patients in
stable state were considered for randomization. 61 patients
agreed to take part in a 3 months ambulatory training pro-
gram. Patients were randomized to one of the following
groups (Trial Flow Figure 1):
– “Individualized Training” (IT): patients participated
in a weekly individualized gym-based outpatient
exercise training. This training program included all
components of exercise training that have been
suggested by the joint American College of Chest
Physicians and the American Association of
Cardiovascular and Pulmonary Rehabilitation
(ACCP/AACVPR) clinical practice guidelines [5].
Each patient received an individual training schedule
at the beginning of the training period based on his
maximal force and endurance time in different
approaches. Details can be found in the Additional
file 1.
– “Non-individualized Training” (NT): patients
participated once weekly as part of a group in different
forms of exercise (calisthenics). The training unit was
divided into three parts: warm-up (free movements,
stretching) for ten minutes; the main part was a forty
minute training which included collectively performed
exercises like ball games, stepping, thera-band training
and dumbbells. The training period was finalized by a
ten minute relaxing exercises period. Details can be
found in the Additional file 1.
The study was approved by the local ethics com-
mittee (Marburg Ethics Committee AZ 123/09,
Marburg, Germany).Randomization
The randomization was performed by a third party (a
statistician from the sleep laboratory of the University
of Marburg). A computer generated list was used to
produce envelopes that were stored in a locked room.
The investigator who wanted to include a patient
called the statistician, reported the patient’s identifica-
tion number and received the allocation to one of
both treatment groups.Assessments
The following assessments have been performed twice; one
time before (M1) and one time after the three months train-
ing program (M2): 6-minute walking test (6-MWT) [21],
health-related quality of life using the St. Georges Respira-
tory Questionnaire (SGRQ) and the COPD-Assessment-
Test (CAT), ultrasound measurement of M. rectus femoris
cross-sectional area (M. rect. fem.) [22], and serum level
measurements of myokines and inflammatory markers.
Table 2 Comorbidities (Chart-based)
Disease IT NT DO Total
Arterial hypertension 5 7 8 20
Obesity 6 5 9 20
Cardiac diseases 5 2 4 11
Cancer 5 1 2 8
Sleep apnea 3 2 3 8
Diabetes mellitus type 2 1 2 2 5
Hyperlipoproteinemia 2 1 4 7
Depression 2 0 2 4
No statistical significant differences could be detected using Kruskal-Wallis test.
Abbreviations are explained in the text.
Table 3 Drop-out reasons of participants, who attended
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Cross-sectional area of the M. rectus femoris was measured
by B-mode ultrasonography as described by Seymour et al.
[22]. While patients were in a supine position, the trans-
ducer was placed perpendicular to the long axis of the thigh
on its superior aspect, three-fifths of the distance from the
anterior superior iliac spine to the superior patellar border.
The area was calculated as an average of three consecutive
measurements.
Laboratory analyses
White blood cells (WBC), serum levels of C-reactive pro-
tein (CRP), interleukin-6 (IL-6), interleukin-8 (IL-8), and
tumor necrosis factor-α (TNF-α) were determined. For the
quantitative determination of serum irisin concentrations a
commercial ELISA kit (Aviscera Bioscience, INC) was used.
Serum samples were diluted 1:8 with dilution buffer and
measured as duplicate in a plate reader (Tecan infinite®
F200pro). The transcription factor PCG1α was analysed in
serum using Western Blot. Further details regarding the
laboratory analyses can be found in the Additional file 1.
Statistic and data analysis
The power calculation was done according to the results
of Barakat et al. who evaluated an outpatient training
program in COPD [23]. We considered our individual-
ized programm to be roughly equally effective (differ-
ence in 6-MWT of 46 m). In the above mentioned paper
the control group received no intervention and had an
increase of 8 m. We anticipated our non-individualized
training to be less effective than the individualized but
better than a pure control group. We anticipated an in-
crease of the 6-MWT in this group of 27 m (the mean
of +46 and +8). We conservatively estimated the stand-
ard deviation to be 18 m (twice as high as reported). A
power calculation was performed (alpha 0.05, power 0.9)
that yielded a group size of 15 patients each (MedCalc
11.1.1.0). Because we expected a drop-out rate of up to
50% we aimed to include 60 patients in the study. All
further analysis was calculated with SPSS 21 (IBM
Ehningen, Germany) and Prism 5.03 (GraphPadTable 1 Baseline characteristics of all randomized
patients
IT NT p-value
Number 31 30 N.A.
Age [years] 64.61 ± 9.02 65.83 ± 8.59 0.484
♀/♂ 8/23 14/16 0.113
BMI [kg/m2] 26.59 ± 6.61 28.41 ± 6.15 0.920
FEV1 [% predicted] 62.01 ± 20.15 68.17 ± 19.8 0.180
COPD stage [I/II/III/IV] 6/15/8/2 8/14/7/1 0.876
Continuous variables were tested using Mann–Whitney-U-Test, categorial
variables were tested using the Fisher-Test. No significant differences were
detected between both groups. Abbreviations are explained in the text.Software, Inc., La Jolla, USA). For comparing two groups
the Mann–Whitney-U-Test for unpaired samples was
performed, for within-group comparisons a Wilcoxon
rank-sum test for paired samples was used. For the in-
vestigation of three groups of the Kruskal-Wallis and in
the case of ordinally scaled variables, the Fisher exact or




61 of 105 invited patients agreed to take part (recruitment
rate: 58.1%). The analysis of the baseline characteristics re-
vealed no statistical significant difference between the
groups (p > 0.05) at baseline (Table 1). Patients in all groups
reported a high number of comorbidities (Table 2).
Drop-out rate
9 patients (NT: n = 3; IT: n = 6) were dissatisfied with the
randomization and did not enter the training. Further 18
patients dropped-out after they attended at least one
training session (drop-out rate: 44.3% of all randomized
patients). 34 patients completed the study with a final
measurement (IT: n = 20; NT: n = 14). There was a dif-
ferential drop-out rate between the 2 groups ifthe training at least one time
Reasons for quitting program IT NT
Cardiac disease 0 1
Dissatisfaction with the training program 0 2
Not enough time 1 2
Orthopedic disease 1 1
Participation in an inpatient rehabilitation 0 1
Pneumological disease 0 1
Psychiatric disorder 1 1
Unknown 2 4
No statistical significant differences could be detected using the Fisher-test.
Abbreviations are explained in the text.
Table 4 Baseline characteristics of dropouts compared to other groups
DO IT p-value# NT p-value## p-value###
Number 27 20 N.A. 14 N.A. N.A.
Age 64.15 ± 8.96 65.45 ± 9.35 0.763 66.93 ± 7.76 0.259 0.619
♀/♂ 13/14 5/15 0.137 4/10 0.321 0.232
BMI 28.6 ± 8.44 28 ± 4.62 0.880 29.03 ± 3.29 0.394 0.702
FEV1 57.91 ± 20.93 66.3 ± 20.42 0.333 73.84 ± 16.89 0.039 0.106
COPD stage I/II/III/IV 5/11/9/2 5/10/4/1 0.732 4/8/2/0 0.356 0.722
We did not find significant differences between DO vs. IT (#), Dropout vs. NT (##) or any of the three groups (###). Continuous variables were analyzed using
Kruskal-Wallis, ordinal-scaled variables were analyzed using Fisher’s exact and Chi square test. Abbreviations are explained in the text.
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In the NT group 51.8% finished the study, whereas in
the IT group (80%) ended the trial (p = 0.04). Reasons
for discontinuation are displayed in Table 3.
In a next step we compared the baseline characteristics
(Table 4) and baseline measurements (Table 5) of the IT,
NT and the drop-out-group (DO). Here, we found differ-
ences in lung function, QoL, and serum markers, indicating
worse baseline conditions in dropouts.6-MWT
Analyzing the exercise capacity by using the 6-MWT we
saw a significant change of the walking distance in the IT-
group (M1 = 407 ± 105.44 m, M2 = 439.37 ± 122.89 m;
p = 0.012, Figure 2a). In the NTgroup no significant change
was observed (M1 = 411.79 ± 64.74 m, M2 = 427.5 ±
84.57 m; p = 0.116, Figure 2a). No significant between
group differences could be observed.Ultrasound-measurement of the M. rectus femoris
In the IT-group a significant chance of the cross-
sectional area of the M. rectus femoris could be identified
(M1 = 6.66 ± 2.7 cm
2, M2 = 7.23 ± 2.38 cm
2; p = 0.049;
Figure 2b), whereas this was not the case in the NT group
(M1 = 7 ± 3.17 cm
2, M2 = 7.05 ± 2.52 cm
2, p = 0.814,
Figure 2b). No significant between group differences
could be observed.Table 5 Baseline measurements of Dropouts compared to oth
DO IT
6 MWT [m] 384.42 ± 98.28 407 ± 105.44
M. rectus femoris [cm2] 7.07 ± 2.47 6.66 ± 2.7
SGRQ 56.19 ± 19.45 46.93 ± 20.72
CAT 20.04 ± 8.08 19.16 ± 6.37
CRP [mg/dl] 11.65 ± 14.65 5.61 ± 2.12
AAT [g/] 1.62 ± 0.29 1.38 ± 0.17
Analysis included comparison of DO vs. Individualized training (IT, #), Dropout vs. no
variables were analyzed using Kruskal-Wallis.Quality of life
We were not able to detect significant differences of
SGRQ and CAT between measurement 1 and 2 in any
of the groups (Figure 3).Serum markers of inflammation and muscle derived
markers
We found no significant differences comparing inflam-
matory and muscle derived markers between both
groups. The values are displayed in Table 6.Discussion
To our knowledge this is the first randomized trial
comparing a low frequency individualized (IT) vs. non-
individualized exercise training (NT) in stable outpatient
COPD patients. We found that only IT significantly im-
proved 6-MWT and muscle rectus femoris cross sectional
area in a group of patients that exercised once weekly.
Baumann et al. randomized 100 patients with moder-
ate to severe COPD to a continuous outpatient interdis-
ciplinary rehabilitation program or standard care [24].
After 26 weeks, the intergroup difference of the 6-MWT
was 59 m in favour of rehabilitation. While the individu-
alized training intervention was similar, the higher inter-
group difference compared to our study (32 m) is
explained by the different comparator (standard care
and non-individualized group training, respectively).er groups
p-value# NT p-value## p-value###
0.345 411.79 ± 64.74 0.318 0.153
0.754 7 ± 3.17 1.000 0.903
0.128 37.45 ± 16.92 0.011 0.028
0.695 14.46 ± 7.37 0.056 0.099
0.048 5 ± 0 0.029 0.006
0.002 1.44 ± 0.23 0.024 0.005
n-individualized training (NT, ##) or any of the three groups (###). Continuous
Figure 2 Exercise capacity and muscle cross-sectional area. Wilcoxon rank-sum test for paired samples was used to test for significant
differences between measurement 1 (M1: before the program) and measurement 2 (M2: after the program).
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fect of a supervised walking training at home in preserv-
ing the hospital-achieved improvement in six-minute
walk test and quality of life in patients with severe
COPD. 30 out of 46 completed the program and walked
2308 m on 157 days. Thus, the effect was seen
in a group of highly compliant patients [25]. No
randomization was done in this study. Significant effects
have also been observed by du Moulin et al. in patients
with moderate COPD. In this randomized trial, ten pa-
tients performed home-based exercise training and 10
patients served as controls. After six months the training
group had better results than the control group in exer-
cise capacity and lung function [26].
Göhl et al. randomized 34 patients to participate in a
multimodular 12 months training program [27]. The
training group demonstrated increases in a variety of pa-
rameters including the 6-MWT (79 m) and SGRQ (>4
units) whereas in the control group no significant
changes were observed. In contrast to our NT group, the
intervention included modules of increasing intensity
and time, resulting in an increase of 2.4 to 4.2 hours of
training per week [27]. The higher intensity and the lon-
ger period of time may very well explain larger effects.Figure 3 Quality of life. Wilcoxon rank-sum test for paired samples was u
(M1: before the program) and measurement 2 (M2: after the program).The cross-sectional area of the M. rectus femoris rose
by 0.57 cm2 in the IT-group. Seymour et al. described
the difference of 115 mm2 between healthy subjects and
COPD patients [22]. In this regard, an increase of
57 mm2 (as found in our study) would roughly bisect
the difference, which might be considered as relevant.
This is further confirmed by earlier data that also dem-
onstrated an increase of cross-sectional area (0.57 cm2)
of the M. rectus femoris after eight weeks of bilateral
high intensity isokinetic knee extensor resistance train-
ing [28]. To the best of our knowledge there are no data
the correlate the rectus femoris cross sectional area to
clinically relevant outcome parameter.
We could not detect any differences in QoL using
SGRQ and CAT. This is most likely explained by the
low-frequency and the low-intensity nature of both pro-
grams. In contrast, higher intensity programs have dem-
onstrated positive effects on health-related quality of life
[9,27,29]. It may be speculated that a low intensity train-
ing program does not result in effects large enough to
measure. In a randomized study of two exercise training
programs of different intensity Camillo et al. observed a
significant improvement in heart rate variability only
after the high-intensity protocol [8]. Effing et al.sed to test for significant differences between measurement 1





M1 M2 M1 M2
CRP [mg/l] 5.6 + 2.1 6.2 + 2.4 1.000 5 + 0 5.2 + 0.6 0.180 0.419
WBC [G/l] 7.5 + 2.1 7.4 + 2.3 0.619 7.2 + 2.1 6.9 + 2.1 0.198 0.666
IL-6 [ng/l] 4.9 + 7.9 3.6 + 2.1 0.324 3.8 + 3.1 5.8 + 6.4 0.170 0.653
IL-8 [ng/l] 8.4 + 3.0 8.8 + 2.9 0.569 8.8 + 2.8 9.4 + 3.6 0.362 0.691
TNF-α [ng/l] 9.9 + 3.5 9.1 + 2.9 0.528 10.7 + 2.9 10.7 + 3.1 0.889 0.587
PGC1- α [relative copies] 0.77 ± 0.77 1.2 ± 1.15 0.017 1.03 ± 0.77 1.16 ± 0.81 0.388 0.832
Irisin [ng/μl] 128.65 ± 14.87 131.5 ± 33.26 0.528 123.67 ± 17.85 128.86 ± 16.68 0.136 0.138
Wilcoxon rank-sum test for paired samples was used to test for significant differences between measurement 1 (M1: before the program) and measurement 2
(M2: after the program). To compare the deltas (M2-M2) between both groups, the Mann–Whitney-U-Test for unpaired samples was performed. Abbreviations are
explained in the text.
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ferences in exercise capacity and daily activity in an
evaluation of the “COPE-active program” [29]. The
interventional exercise program consisted of a 6-month
“compulsory” period (3 sessions/week) and subsequently
a 5-month “optional” period (2 sessions/week). One ses-
sion/week (control group) consisted of unsupervised
home-based exercise training. Of 153 patients, 74 inter-
vention and 68 control patients completed the one-year
follow-up. Again, significant effects were seen in a rela-
tively intense program (2 – 3 sessions/week) [29].
Finally, Probst et al. compared the effects of a high-
intensity whole-body endurance-and-strength program
and a low-intensity calisthenics-and-breathing-exercises
program on different outcome parameters [9]. Both
groups underwent 3 sessions per week for 12 weeks. Ex-
ercise capacity and muscle force significantly improved
only in the endurance-and-strength group. Health-
related quality of life and functional status improved
significantly in both groups. Even the “low-intensity”
exercise program included 3 sessions per week [9]. In
summary, most “positive studies” published were of
higher intensity than the two programs we conducted.
A major problem of all these studies is the inclusion
criteria and the compliance of patients. One recent re-
view pointed out that the majority of positive studies did
not clarify which patients were included [20]. Only 12%
of studies included in this review reported the number
of contacted patients. In these studies only 28% com-
pleted the program. Altogether 75% of the patients suit-
able for exercise programs were omitted due to
sampling exclusion and dropout. The authors concluded
that most of the study populations were not representa-
tive of the target population. In general, adherence is a
common problem in rehabilitation studies with COPD
patients. Drop-out-rates up to 50% are not unusual
[5,28-30]. The main causes are often difficult to clarify.
By telephone interviews the most often mentioned rea-
sons were disease-related drop-out, disagreement withgroup assignment, and missing motivation [20]. Missing
motivation may be a sign of depression which has been
reported to be a frequent comorbidity in COPD [30,31].
No clear recommendation exists how to deal with these
frequently occurring problems.
When considering only patients that entered the train-
ing period we observed a differential dropout, with sig-
nificantly more subjects stopping NT than IT (13/27 vs.
5/25; p = 0.04). Assessing possible reasons for this
phenomenon, the main causes were not significantly dif-
ferent between both groups (Table 3). To our know-
ledge, published literature does not provide plausible
data to sufficiently explain this issue.
On a closer view it becomes clear that the patients
that dropped out had a lower quality of life, worse lung
function and elevated inflammatory markers like AAT
and CRP (Table 5). In summary, patients with a worse
baseline condition had a higher probability to drop out.
This is in line with the observation that a higher FEV1,
CRQ-Score or a shorter distance to the location where
training takes place would increase the adherence [28].
We could demonstrate an increase of PGC1-α in the
IT group. Since the Irisin values did not show a subse-
quent increase, the relevance of this result remains un-
clear. We could not find significant changes in all other
measured inflammatory markers and myokines which
strengthenes the assumption that low intensity training
of 1 hr /week regardless of the modality is not sufficient.
The study has significant limitations. First, we included
a relatively small number of patients from a wide range
of the disease (GOLD stage I – IV). As a potential train-
ing effect might be achievable in some stages of the dis-
ease and not in others, this may have influenced the
results. On the other hand, as neither the mean FEV1
nor the GOLD stages differed significantly between both
groups we do not think that the results have biased on a
(potentially missed) between-group differences. Sec-
ondly, we observed a high dropout rate (as other groups
before). This may have attenuated the effect of training.
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questionnaires.
Taken together, this is to our knowledge the first study
comparing different low-intensity training approaches in
stable COPD patients in a randomized way. The data
seem to favor the individualized low frequency training
program but do not result in significant improvements
of quality of life.
At the moment, it remains unclear how to resolve the
discrepancies between guideline recommendations and
existing structures. In many countries, we do not have
the infrastructure to train our patients 3–5 times
per week (as recommended in recent international
guidelines [32]). Furthermore a significant proportion of
patients would not attend more frequent training oppor-
tunities. This results in the need to optimize once
weekly training. We believe, that - beside the training
approach - the training intensity is an important trigger
of success. We conclude, that if low intensity training
was chosen and only once weekly training can be prof-
fered, we would suggest to offer an individualized train-
ing. The significance of exercise-intensity increase has to
be evaluated in further studies.
Consent
Written informed consent was obtained from the patient
for the publication of this report and any accompanying
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